Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT07301372
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 132 participants
- Registry
-
NCT07301372
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07301372. Randomized; single masking; primary purpose treatment. Start 2025-10-30 (actual); primary completion 2026-03-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
- Acronym
- EPOCH-LYSIS
- Condition
- Acute Stroke
- Intervention (Drug)
- Ivolumab 420mg (three vials)
- Lead sponsor
- The Affiliated Hospital of Xuzhou Medical University
Record details
- Record id
cardio:ct-nct07301372- Content hash
694dedf9020e43afba58f2ef7c4fc01af5b5c75e01acfd3d0d4fc24e0bccf6fe